Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

GERD prevalence in migraine patients and the implication for acute migraine treatment.

Katić BJ, Golden W, Cady RK, Hu XH.

J Headache Pain. 2009 Feb;10(1):35-43. doi: 10.1007/s10194-008-0083-1.

2.

Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.

Ruszniewski P, Soufflet C, Barthélémy P.

Aliment Pharmacol Ther. 2008 Nov 1;28(9):1134-9. doi: 10.1111/j.1365-2036.2008.03821.x.

3.

Acute migraine treatment with oral triptans and NSAIDs in a managed care population.

Ng-Mak DS, Hu XH, Chen YT, Ma L.

Headache. 2008 Sep;48(8):1176-85.

PMID:
18819177
4.

A retrospective, case-control pilot study of the natural history of pediatric gastroesophageal reflux.

Young RJ, Lyden E, Ward B, Vanderhoof JA, DiBaise JK.

Dig Dis Sci. 2007 Feb;52(2):457-62.

PMID:
17211703
5.

Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.

MacGregor EA, Brandes J, Eikermann A.

Headache. 2003 Jan;43(1):19-26.

PMID:
12864754
6.

Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan.

Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Nishikawa H, Arakawa T.

J Gastroenterol Hepatol. 2005 Jan;20(1):26-9.

PMID:
15610442
7.

Prevalence of heartburn and gastroesophageal reflux disease in the urban Brazilian population.

Moraes-Filho JP, Chinzon D, Eisig JN, Hashimoto CL, Zaterka S.

Arq Gastroenterol. 2005 Apr-Jun;42(2):122-7.

8.

Epidemiological study on the incidence of gastroesophageal reflux disease symptoms in patients in acute treatment with NSAIDs.

Martín-de-Argila C, Martínez-Jiménez P.

Expert Rev Gastroenterol Hepatol. 2013 Jan;7(1):27-33. doi: 10.1586/egh.12.61.

PMID:
23265146
9.

Gastro-esophageal reflux disease in northwestern Tabriz, Iran.

Khoshbaten M.

Indian J Gastroenterol. 2003 Jul-Aug;22(4):138-9.

PMID:
12962436
10.

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.

Cady RK, Banks J, Jones BA, Campbell J.

Curr Med Res Opin. 2009 Nov;25(11):2711-21. doi: 10.1185/03007990903285449.

PMID:
19778164
11.

[Multicentre study "Epidemiology of gastroesophageal reflux disease in Russia"(MEGRE): first results].

Lazebnik LB, Masharova AA, Bordin DS, Vasil'ev IuV, Tkachenko EI, Abdulkhakov RA, Butov MA, Eremina EIu, Zinchuk LI, Tsukanov VV.

Eksp Klin Gastroenterol. 2009;(6):4-12. Russian.

PMID:
20205320
12.

Prescription patterns in preventive and abortive migraine medication.

Sumelahti ML, Mattila K, Sillanmäki L, Sumanen M.

Cephalalgia. 2011 Dec;31(16):1659-63. doi: 10.1177/0333102411427602.

PMID:
22116941
13.

The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity.

Dean BB, Aguilar D, Johnson LF, Fass R, Orr WC, McGuigan JE, Calimlim B, Yan N, Morgenstern D, Dubois RW.

Dig Dis Sci. 2010 Apr;55(4):952-9. doi: 10.1007/s10620-009-0885-2.

PMID:
19693672
14.

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea.

Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, Han SW, Choi KY, Chung IS.

Am J Gastroenterol. 2005 Apr;100(4):747-53.

PMID:
15784014
15.

Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey.

Nouraie M, Razjouyan H, Assady M, Malekzadeh R, Nasseri-Moghaddam S.

Arch Iran Med. 2007 Jul;10(3):289-94.

16.
18.

Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients.

Ortiz V, Ponce M, Fernández A, Martínez B, Ponce JL, Garrigues V, Ponce J.

Obesity (Silver Spring). 2006 Apr;14(4):696-700.

19.

Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease.

Bor S, Kitapcioglu G, Solak ZA, Ertilav M, Erdinc M.

J Gastroenterol Hepatol. 2010 Feb;25(2):309-13. doi: 10.1111/j.1440-1746.2009.06035.x.

PMID:
19817951
20.

Acute migraine treatment: patterns of use and satisfaction in a clinical population.

Malik SN, Hopkins M, Young WB, Silberstein SD.

Headache. 2006 May;46(5):773-80.

PMID:
16643580
Items per page

Supplemental Content

Support Center